Wildcat Capital Management LLC's Q1 2026 13F: 1 exit
Form 13F-HR for the quarter ended Mar 31, 2026 · filed May 1, 2026 · 2 reported positions · accession 0001999371-26-009738
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Exited | PROCORE TECHNOLOGIES INC (PCOR) | 0.2% | — | −0.2 pts | −3,851 sh | −100% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 100.0% of the equity book
Changes in the top 10 this quarter: PCOR left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | FRONTIER GROUP HLDGS INC (ULCC) | 96.9% | 93.3% | |
| 2 | ALLOGENE THERAPEUTICS INC (ALLO) | 2.9% | 6.7% | |
| — | PROCORE TECHNOLOGIES INC (PCOR) | 0.2% | 0.0% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).